APO CHLORPROMAZINE 111.4 MG
CHLORPROMAZINE HYDROCHLORIDE : 111.4 MG · DIN 00312681 · APOTEX INC
Health Canada status: CANCELLED POST MARKET
What is APO CHLORPROMAZINE?
APO CHLORPROMAZINE 111.4 MG contains CHLORPROMAZINE HYDROCHLORIDE : 111.4 MG. It is listed in the Health Canada Drug Product Database under DIN 00312681, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Aug-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00312681 |
|---|---|
| Brand name | APO CHLORPROMAZINE |
| Generic / active ingredient | CHLORPROMAZINE HYDROCHLORIDE : 111.4 MG |
| Manufacturer | APOTEX INC |
| Strength | 111.4 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AA01 CHLORPROMAZINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 05-Aug-2011 |
What can be used instead?
Other Canadian products sharing ATC code N05AA01 CHLORPROMAZINE. 3 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TEVA-CHLORPROMAZINE | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00232831 |
| TEVA-CHLORPROMAZINE | 25.0 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00232823 |
| TEVA-CHLORPROMAZINE | 50.0 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00232807 |
| APO CHLORPROMAZINE | 27.9 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00312703 |
| APO CHLORPROMAZINE | 55.7 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00312673 |
| CHLORPROM TAB 100MG | 111.6 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00271128 |
| CHLORPROM TAB 25MG | 27.9 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00295086 |
| CHLORPROM TAB 50MG | 55.8 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00271101 |
| CHLORPROMANYL 20 SYR | 22.2 MG | DROPS | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 00580988 |
| CHLORPROMANYL 40 DROPS SYR 44.5MG/ML | 44.5 MG | SYRUP | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 00690805 |
Who else supplies CHLORPROMAZINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CHLORPROMAZINE appears in 27 registered pack listings across 6 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.